doi: 10.2337/dc13-0465
Water/Aqua/Eau, 1,2-Hexanediol, Phenoxyethanol, Avena Sativa (Oat) Kernel Extract, Lactic Acid, Acrylates/C10-30 Alkyl Acrylate Crosspolymer, Propanediol, Sodium Hydroxide, Silica Cetyl Silylate, Sodium Polyacrylate, Citric Acid, Allantoin, Caffeine, Dimethyl MEA, Silica, Butylene Glycol, Disodium EDTA, Gentiana Lutea Root Extract, Caprylyl Glycol, Sodium Hyaluronate, Ethylhexylglycerin, S-Palmitoylglutathione, Tetrapeptide-1, Potassium Sorbate, Acetic Acid, Acetyl Hexapeptide-8, Arginine/Lysine Polypeptide, Iron Oxides (CI 77491), Titanium Dioxide (CI 77891) For the latest information, it is recommended to review the ingredient list printed on the packaging of the product prior to usage or consumption
Most people experience only mild discomfort during self-injections, especially with SubQ injections that use smaller, finer needles
Protocols commonly use 200500 mcg subcutaneously, once or twice daily, in 46 week cycles, but there is no FDA-approved product or official dosing
In September 2023 GHK-Cu, also known as copper peptide or glycyl-l-histidyl-l-lysine copper complex, was added to the 503A bulks list in category 1
ACS Chem Neurosci 13:486496